CA
PACB icon

Cetera Advisors’s Pacific Biosciences PACB Stock Holding History

Cetera Advisors’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$98.3K Buy
+26,212
New +$153K ﹤0.01% 2309

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Cetera Advisors's PACB Position: Q1 2024 in Review

Cetera Advisors opened a new position in Pacific Biosciences (PACB) in Q1 2024: 26,212 shares worth $98.3K. The stake represents ﹤0.01% of the portfolio and ranks #2309 among its holdings.

268 funds tracked by Wall St. Rank hold PACB as of Q1 2024.

  • Cetera Advisors held 26,212 shares of Pacific Biosciences worth $98.3K as of Q1 2024.
  • Pacific Biosciences was a new Cetera Advisors position in Q1 2024.
  • Pacific Biosciences made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2309 holding.
  • 268 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.